Clinical trials: Upper Extremity Orthopedic Surgery Patients
- Condition Upper Extremity Orthopedic Surgery Patients
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Postoperative Pain
Maxigesic® IV Phase 3 Exposure Study
The study aims to determine the tolerability of repeated doses of Maxigesic® IV over an extended period of exposure.
- Trial name
- NCT04005755
- Testing
- Maxigesic® IV
- Where
- 4 sites in United States, New Zealand
- Volunteers
- 232 people
- Sponsor
- AFT Pharmaceuticals, Ltd.